Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

P. L. Zinzani; E. Derenzini; C. Pellegrini; L. Rigacci; A. Fabbri; L. Gandolfi; L. Argnani; B. Casadei; A. Pulsoni; M. Gobbi; A. Perotti; A. Zaccaria; Maria Teresa Voso; M. G. Cabras; A. De Renzo

doi:10.1093/annonc/mdr633

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

P. L. Zinzani, E. Derenzini, C. Pellegrini, L. Rigacci, A. Fabbri, L. Gandolfi, L. Argnani, B. Casadei, A. Pulsoni, M. Gobbi, A. Perotti, A. Zaccaria, Maria Teresa Voso, M. G. Cabras, A. De Renzo

Research output: Contribution to journal › Article

10 Citations (Scopus)

Abstract

No abstract

Original language	English
Pages (from-to)	805-807
Number of pages	3
Journal	Annals of Oncology
Volume	23
DOIs	https://doi.org/10.1093/annonc/mdr633
Publication status	Published - 2012
Externally published	Yes

Keywords

Fludarabine
Follicular lymphoma

Access to Document

10.1093/annonc/mdr633

Cite this

Zinzani, P. L., Derenzini, E., Pellegrini, C., Rigacci, L., Fabbri, A., Gandolfi, L., Argnani, L., Casadei, B., Pulsoni, A., Gobbi, M., Perotti, A., Zaccaria, A., Voso, M. T., Cabras, M. G., & De Renzo, A. (2012). Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). Annals of Oncology, 23, 805-807. https://doi.org/10.1093/annonc/mdr633

@article{8888b99f337949c7837be6aa5047ad11,

title = "Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)",

abstract = "No abstract",

keywords = "Fludarabine, Follicular lymphoma, Fludarabine, Follicular lymphoma",

author = "Zinzani, {P. L.} and E. Derenzini and C. Pellegrini and L. Rigacci and A. Fabbri and L. Gandolfi and L. Argnani and B. Casadei and A. Pulsoni and M. Gobbi and A. Perotti and A. Zaccaria and Voso, {Maria Teresa} and Cabras, {M. G.} and {De Renzo}, A.",

year = "2012",

doi = "10.1093/annonc/mdr633",

language = "English",

volume = "23",

pages = "805--807",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Attuale:OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP Kluwer Academic Publishers:Journals Department, PO Box 322, 3300 AH Dordrecht Netherlands:011 31 78 6576050, EMAIL: [email protected], [email protected], INTERNET: http://www.kluwerlaw.com, Fax: 011 31 78 6576254",

}

Zinzani, PL, Derenzini, E, Pellegrini, C, Rigacci, L, Fabbri, A, Gandolfi, L, Argnani, L, Casadei, B, Pulsoni, A, Gobbi, M, Perotti, A, Zaccaria, A, Voso, MT, Cabras, MG & De Renzo, A 2012, 'Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)', Annals of Oncology, vol. 23, pp. 805-807. https://doi.org/10.1093/annonc/mdr633

TY - JOUR

T1 - Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

AU - Zinzani, P. L.

AU - Derenzini, E.

AU - Pellegrini, C.

AU - Rigacci, L.

AU - Fabbri, A.

AU - Gandolfi, L.

AU - Argnani, L.

AU - Casadei, B.

AU - Pulsoni, A.

AU - Gobbi, M.

AU - Perotti, A.

AU - Zaccaria, A.

AU - Voso, Maria Teresa

AU - Cabras, M. G.

AU - De Renzo, A.

PY - 2012

Y1 - 2012

N2 - No abstract

AB - No abstract

KW - Fludarabine

KW - Follicular lymphoma

KW - Fludarabine

KW - Follicular lymphoma

UR - http://hdl.handle.net/10807/2744

U2 - 10.1093/annonc/mdr633

DO - 10.1093/annonc/mdr633

M3 - Article

SN - 0923-7534

VL - 23

SP - 805

EP - 807

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this